Enzymology in Drug Discovery

Enzymes are the proteins in the drug design that act as drug targets for the diseases in the process of drug discovery and development. There are number of drug targets involved in the designing of the drug.

Drug target as a nucleic acid or a protein (e.g. an enzyme, a receptor) whose activity can be modified by a drug. The drug can be a small-molecular-weight chemical compound or a biological, such as an antibody or a recombinant protein. The drug target should have been shown to be effective/mechanistically involved in the disease by relevant in vitro or in vivo models.

  • Drug designing using enzymes
  • Drug development using enzymes
  • Drug modelling
  • Drug targeting

Related Conference of Enzymology in Drug Discovery

July 13-14, 2018

13th International Conference on Structural Biology

Toronto | Ontario | Canada
July 23-24, 2018

Lipids 2018

Birmingham, UK
August 27-28, 2018

5th International Conference on Glycobiology, Lipids & Proteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Biophysics

Los Angeles, California, USA

Enzymology in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in